Premetastatic niche and tumor-related leukocytosis: a close relationship that cannot be ignored in uterine cancer patients
Premetastatic niche and tumor-related leukocytosis: a close relationship that cannot be ignored in uterine cancer patients |
|
https://doi.org/10.18632/oncotarget.26425
Seiji Mabuchi,
Tomoyuki Sasano,
and Naoko Komura
|
| 36889-36890 |
Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradication
Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradication |
|
https://doi.org/10.18632/oncotarget.26382
Ka Shing Cheung,
and Wai K. Leung
|
| 36891-36893 |
Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib
Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib |
|
https://doi.org/10.18632/oncotarget.26380
Paula Jiménez-Fonseca,
Miguel Navarro Martín,
Alberto Carmona-Bayonas,
Alfonso Calvo,
Javier Fernández-Mateos,
Miriam Redrado,
Jaume Capdevila,
Nieves Martínez Lago,
Adelaida Lacasta,
Javier Muñarriz,
Ángel Segura,
Josep Fuster,
Francisco Barón,
Marta Llanos,
Raquel Serrano,
Alfredo Castillo,
Juan Jesús Cruz Hernández,
and Enrique Grande
|
| 36894-36905 |
Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study
Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study |
|
https://doi.org/10.18632/oncotarget.26385
Despoina Kalapanida,
Flora Zagouri,
Maria Gazouli,
Eleni Zografos,
Constantine Dimitrakakis,
Spyridon Marinopoulos,
Aris Giannos,
Theodoros N. Sergentanis,
Efstathios Kastritis,
Evangelos Terpos,
and Meletios-Athanasios Dimopoulos
|
| 36906-36913 |
TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase
TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase |
|
https://doi.org/10.18632/oncotarget.26398
Elena Brin,
Katherine Wu,
Eleanor Dagostino,
Mario Meng-Chiang Kuo,
Yudou He,
Wei-Jong Shia,
Li-Chang Chen,
Mariusz Stempniak,
Richard Hickey,
Robert Almassy,
Richard Showalter,
and James Thomson
|
| 36914-36928 |
Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients
Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients |
|
https://doi.org/10.18632/oncotarget.26405
Paola Montes,
Martin Kerick,
Mónica Bernal,
Francisca Hernández,
Pilar Jiménez,
Pilar Garrido,
Ana Márquez,
Manuel Jurado,
Javier Martin,
Federico Garrido,
and Francisco Ruiz-Cabello
|
| 36929-36944 |
Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas
Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas |
|
https://doi.org/10.18632/oncotarget.26421
James L. Figarola,
Jyotsana Singhal,
Sharad Singhal,
Jyotirmoy Kusari,
and Arthur Riggs
|
| 36945-36965 |
Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer
Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer |
|
https://doi.org/10.18632/oncotarget.26426
Satoshi Tamada,
Taro Iguchi,
Minoru Kato,
Jumpei Asakawa,
Kazuaki Kita,
Sayaka Yasuda,
Takeshi Yamasaki,
Yudai Matsuoka,
Kazuyuki Yamaguchi,
Kentaro Matsumura,
Ishun Go,
Tetsuji Ohmachi,
and Tatsuya Nakatani
|
| 36966-36974 |
Insight into the PTEN – p85α interaction and lipid binding properties of the p85α BH domain
Insight into the PTEN – p85α interaction and lipid binding properties of the p85α BH domain |
|
https://doi.org/10.18632/oncotarget.26432
Jeremy D.S. Marshall,
Paul Mellor,
Xuan Ruan,
Dielle E. Whitecross,
Stanley A. Moore,
and Deborah H. Anderson
|
| 36975-36992 |
CD39+ regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function
CD39+ regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function |
|
https://doi.org/10.18632/oncotarget.26435
Filip Ahlmanner,
Patrik Sundström,
Paulina Akeus,
Jenny Eklöf,
Lars Börjesson,
Bengt Gustavsson,
Elinor Bexe Lindskog,
Sukanya Raghavan,
and Marianne Quiding-Järbrink
|
| 36993-37007 |
The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer
The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer |
|
https://doi.org/10.18632/oncotarget.26438
Nobuhiro Hanai,
Michi Sawabe,
Takahiro Kimura,
Hidenori Suzuki,
Taijiro Ozawa,
Hitoshi Hirakawa,
Yujiro Fukuda,
and Yasuhisa Hasegawa
|
| 37008-37016 |
Second-line treatment after sunitinib therapy in patients with renal cell carcinoma: a comparison of axitinib and mammalian target of rapamycin inhibitors
Second-line treatment after sunitinib therapy in patients with renal cell carcinoma: a comparison of axitinib and mammalian target of rapamycin inhibitors |
|
https://doi.org/10.18632/oncotarget.26439
Satoshi Tamada,
Taro Iguchi,
Minoru Kato,
Sayaka Yasuda,
Takeshi Yamasaki,
and Tatsuya Nakatani
|
| 37017-37025 |
NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo
NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.26443
Steve Swenson,
Catalina Silva-Hirschberg,
Weijun Wang,
Anupam Singh,
Florence M. Hofman,
Kristen L. Chen,
Axel H. Schönthal,
and Thomas C. Chen
|
| 37026-37041 |
Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma
Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma |
|
https://doi.org/10.18632/oncotarget.26455
Nicholas M. Szigetvari,
Deepika Dhawan,
José A. Ramos-Vara,
Christopher P. Leamon,
Patrick J. Klein,
A. Audrey Ruple,
Hock Gan Heng,
Michael R. Pugh,
Satish Rao,
Iontcho R. Vlahov,
Pierre L. Deshuillers,
Philip S. Low,
Lindsey M. Fourez,
Ashleigh M. Cournoyer,
and Deborah W. Knapp
|
| 37042-37053 |
Metformin alters H2A.Z dynamics and regulates androgen dependent prostate cancer progression
Metformin alters H2A.Z dynamics and regulates androgen dependent prostate cancer progression |
|
https://doi.org/10.18632/oncotarget.26457
Monica Tyagi,
Manjinder S. Cheema,
Deanna Dryhurst,
Christopher H. Eskiw,
and Juan Ausió
|
| 37054-37068 |
Radioresistance of cancer cells, integrin αvβ3 and thyroid hormone
Radioresistance of cancer cells, integrin αvβ3 and thyroid hormone |
|
https://doi.org/10.18632/oncotarget.26434
John T. Leith,
Shaker A. Mousa,
Aleck Hercbergs,
Hung-Yun Lin,
and Paul J. Davis
|
| 37069-37075 |
Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells
Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells |
|
https://doi.org/10.18632/oncotarget.26474
Erminia Romano,
Nicole Rufo,
Hannelie Korf,
Chantal Mathieu,
Abhishek D. Garg,
and Patrizia Agostinis
|
| 37076-37076 |
Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability |
|
https://doi.org/10.18632/oncotarget.26475
Enrico Munari,
Giuseppe Zamboni,
Marcella Marconi,
Marco Sommaggio,
Matteo Brunelli,
Guido Martignoni,
George J. Netto,
Francesca Moretta,
Maria Cristina Mingari,
Matteo Salgarello,
Alberto Terzi,
Vincenzo Picece,
Carlo Pomari,
Gianluigi Lunardi,
Alberto Cavazza,
Giulio Rossi,
Lorenzo Moretta,
and Giuseppe Bogina
|
| 37077-37077 |
